HI
JAZZ icon

Handelsinvest Investeringsforvaltning’s Jazz Pharmaceuticals JAZZ Stock Holding History

Handelsinvest Investeringsforvaltning’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$801K Sell
6,648
-1,264
-16% -$155K 0.39% 70
2023
Q4 		$973K Buy
+7,912
New +$987K 0.4% 67

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
PCM
Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Handelsinvest Investeringsforvaltning's JAZZ Position: Q1 2024 in Review

Handelsinvest Investeringsforvaltning reduced its Jazz Pharmaceuticals (JAZZ) stake by 16% in Q1 2024, selling an estimated $155K and leaving 6,648 shares worth $801K. The position accounts for 0.39% of the portfolio, ranked #70.

Handelsinvest Investeringsforvaltning first reported a position in JAZZ in Q4 2023 and has held it in 2 quarters since. The position peaked at $973K in Q4 2023. 481 funds tracked by Wall St. Rank hold JAZZ as of Q1 2024.

  • Handelsinvest Investeringsforvaltning held 6,648 shares of Jazz Pharmaceuticals worth $801K as of Q1 2024.
  • Handelsinvest Investeringsforvaltning sold 1,264 Jazz Pharmaceuticals shares in Q1 2024, an estimated $155K.
  • Jazz Pharmaceuticals made up 0.39% of Handelsinvest Investeringsforvaltning's portfolio in Q1 2024, its #70 holding.
  • Handelsinvest Investeringsforvaltning first reported a position in Jazz Pharmaceuticals in Q4 2023 and has held it in 2 quarters since.
  • Handelsinvest Investeringsforvaltning's Jazz Pharmaceuticals position peaked at $973K in Q4 2023.
  • 481 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2024.

Based on Handelsinvest Investeringsforvaltning's 13F filing for Q1 2024, filed 19 Apr 2024.